Search Results - "Villanueva, Erika B."
-
1
In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
Published in Molecular therapy (01-12-2014)“…Huntington disease (HD) is a dominant, genetic neurodegenerative disease characterized by progressive loss of voluntary motor control, psychiatric disturbance,…”
Get full text
Journal Article -
2
Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
Published in Neurobiology of disease (01-04-2015)“…Abstract Huntington disease (HD) is an inherited, fatal neurodegenerative disease with no disease-modifying therapy currently available. In addition to…”
Get full text
Journal Article -
3
-
4
Moderate increase in temperature may exacerbate neuroinflammatory processes in the brain: Human cell culture studies
Published in Journal of neuroimmunology (01-04-2011)“…Abstract The effect of a moderate, physiologically relevant rise in temperature on several neuroinflammatory parameters was investigated in vitro using human…”
Get full text
Journal Article -
5
Secreted phospholipase A2 group IIA is a neurotoxin released by stimulated human glial cells
Published in Molecular and cellular neuroscience (01-04-2012)“…Neuroinflammation, which is one of the hallmarks of neurodegenerative disorders such as Alzheimer's disease, involves secretion of pro-inflammatory mediators…”
Get full text
Journal Article -
6
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes
Published in Human molecular genetics (01-09-2016)“…Huntington disease (HD) model mice with heterozygous knock-in (KI) of an expanded CAG tract in exon 1 of the mouse huntingtin (Htt) gene homolog genetically…”
Get full text
Journal Article -
7
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
Published in Nucleic acids research (01-11-2013)“…Autosomal dominant diseases such as Huntington's disease (HD) are caused by a gain of function mutant protein and/or RNA. An ideal treatment for these diseases…”
Get full text
Journal Article -
8
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
Published in Scientific reports (15-07-2015)“…Quantitation of huntingtin protein in the brain is needed, both as a marker of Huntington disease (HD) progression and for use in clinical gene silencing…”
Get full text
Journal Article -
9
Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia
Published in Molecular and cellular neuroscience (01-05-2014)“…Microglia represent mononuclear phagocytes in the brain and perform immune surveillance, recognizing a number of signaling molecules released from surrounding…”
Get full text
Journal Article -
10
Neuronal TNFα, Not α‐Syn, Underlies PDD‐Like Disease Progression in IFNβ‐KO Mice
Published in Annals of neurology (01-11-2021)“…Objective Parkinson's disease (PD) manifests in motor dysfunction, non‐motor symptoms, and eventual dementia (PDD). Neuropathological hallmarks include…”
Get full text
Journal Article -
11
HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo
Published in Human molecular genetics (15-01-2018)“…Abstract Oxidative stress is a prominent feature of Huntington disease (HD), and we have shown previously that reduced levels of hace1 (HECT domain and Ankyrin…”
Get full text
Journal Article -
12
A fully humanized transgenic mouse model of Huntington disease
Published in Human molecular genetics (01-01-2013)“…Silencing the mutant huntingtin gene (muHTT) is a direct and simple therapeutic strategy for the treatment of Huntington disease (HD) in principle. However,…”
Get full text
Journal Article -
13
Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents
Published in Bioorganic & medicinal chemistry (01-03-2010)“…A number of in vitro and in vivo assays were used to identify four novel pyrazolyl-2,4-thiazolidinediones ( 5a– c, 7b) as potential anti-inflammatory and…”
Get full text
Journal Article -
14
Secreted phospholipase A(2) group IIA is a neurotoxin released by stimulated human glial cells
Published in Molecular and cellular neuroscience (01-04-2012)“…Neuroinflammation, which is one of the hallmarks of neurodegenerative disorders such as Alzheimer's disease, involves secretion of pro-inflammatory mediators…”
Get full text
Journal Article -
15
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles
Published in Human molecular genetics (15-03-2017)“…Huntington disease (HD) is a neurodegenerative disease caused by a mutation in the huntingtin (HTT) gene. HTT is a large protein, interacts with many partners…”
Get full text
Journal Article -
16
Synthesis and biological evaluation of novel pyrazole compounds
Published in Bioorganic & medicinal chemistry (01-08-2010)“…A novel dipyrazole ethandiamide lead compound 3 has been synthesized and reacted with a number of nucleophiles. Two compounds (3 and 4d) were identified as…”
Get full text
Journal Article -
17
Cultured adult porcine astrocytes and microglia express functional interferon-γ receptors and exhibit toxicity towards SH-SY5Y cells
Published in Brain research bulletin (28-02-2011)“…Abstract In vitro cultures of various glial cell types are common systems used to model neuroinflammatory processes associated with age-dependent human…”
Get full text
Journal Article -
18
I09 Antibodies inhibit cell to cell transmission of mutant HTT
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2018)“…The toxic functions of the mutant Huntingtin protein (mutHTT) were studied extensively and in addition to neuronal based symptoms, also peripheral changes upon…”
Get full text
Journal Article -
19
696. Pre-Clinical Evaluation of Allele-Specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
Published in Molecular therapy (01-05-2015)Get full text
Journal Article